Evidence map›Paper›PMID 26156216›Full record

ReviewNutrition research reviews2015

Towards microbial fermentation metabolites as markers for health benefits of prebiotics.

Kristin A Verbeke, Alan R Boobis, Alessandro Chiodini, Christine A Edwards, Anne Franck, Michiel Kleerebezem, Arjen Nauta, Jeroen Raes, Eric A F van Tol, Kieran M Tuohy

Open access · hybridAbstract readReview
In one paragraph

Review in Nutrition research reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 152 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
152citing papers in PubMed, 4 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

152 citing papers in PubMed, 4 syntheses or guidelines pooled it, 331 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Effects ofNutrients · 2020
    Trial
  8. Associations between the gut microbiota and host responses to high altitude.American journal of physiology. Gastrointestinal and liver physiology · 2018
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Review
  13. Article
  14. Article
  15. A Combination of Inulin and Long-Chain Fructooligosaccharides EnhancesJournal of agricultural and food chemistry · 2026
    Article
  16. A Developmental Perspective on the Intestinal Microbiota in Crohn's Disease.International journal of molecular sciences · 2026
    Review
  17. Review
  18. Observational
  19. Article
  20. Article

92 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 4 countries.

Kristin A VerbekeTranslational Research in Gastrointestinal Disorders (TARGID), KU Leuven and Leuven Food Science and Nutrition Research Center (LFoRCe),Leuven,Belgium.
Alan R BoobisDepartment of Medicine, Imperial College London,London,UK.
Alessandro ChiodiniFormerly ILSI Europe,Box 6, Avenue Emmanuel Mounier 83,BE-1200,Brussels,Belgium; now European Commission, Research Executive Agency (REA) Unit B2, Brussels, Belgium.
Christine A EdwardsHuman Nutrition School of Medicine, College of MVLS, University of Glasgow,Glasgow,Scotland.
Anne FranckCargill,Vilvoorde,Belgium.
Michiel KleerebezemHost Microbe Interactomics, Wageningen University,Wageningen,The Netherlands.
Arjen NautaFrieslandCampina,Amersfoort,The Netherlands.
Jeroen RaesMicrobiology and Immunology, Rega Institute, KU Leuven, Leuven; VIB, Leuven; DBIT, Vrije Universiteit Brussel,Brussels,Belgium.
Eric A F van TolMead Johnson Nutrition,Nijmegen,The Netherlands.
Kieran M TuohyNutrition and Nutrigenomics, Research and Innovation Centre-Fondazione Edmund Mach,Trento,Italy.
Cargill (Belgium) · BEFondazione Edmund Mach · ITFrieslandCampina (Netherlands) · NLImperial College London · GBInternational Life Sciences Institute Europe · BEKU Leuven · BEUniversity of Glasgow · GBVIB-KU Leuven Center for Microbiology · BEWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Available evidence on the bioactive, nutritional and putative detrimental properties of gut microbial metabolites has been evaluated to support a more integrated view of how prebiotics might affect host health throughout life. The present literature inventory targeted evidence for the physiological and nutritional effects of metabolites, for example, SCFA, the potential toxicity of other metabolites and attempted to determine normal concentration ranges. Furthermore, the biological relevance of more holistic approaches like faecal water toxicity assays and metabolomics and the limitations of faecal measurements were addressed. Existing literature indicates that protein fermentation metabolites (phenol, p-cresol, indole, ammonia), typically considered as potentially harmful, occur at concentration ranges in the colon such that no toxic effects are expected either locally or following systemic absorption. The endproducts of saccharolytic fermentation, SCFA, may have effects on colonic health, host physiology, immunity, lipid and protein metabolism and appetite control. However, measuring SCFA concentrations in faeces is insufficient to assess the dynamic processes of their nutrikinetics. Existing literature on the usefulness of faecal water toxicity measures as indicators of cancer risk seems limited. In conclusion, at present there is insufficient evidence to use changes in faecal bacterial metabolite concentrations as markers of prebiotic effectiveness. Integration of results from metabolomics and metagenomics holds promise for understanding the health implications of prebiotic microbiome modulation but adequate tools for data integration and interpretation are currently lacking. Similarly, studies measuring metabolite fluxes in different body compartments to provide a more accurate picture of their nutrikinetics are needed.

Indexed as

Health PromotionPrebioticsBacteriaCarbohydratesColonFatty AcidsFatty Acids, VolatileFecesFermentationGastrointestinal MicrobiomeHumansIntestinesMetabolomicsMetagenomicsPlantsPolyphenolsCarbohydratesFatty AcidsFatty Acids, VolatilePolyphenolsPrebioticsProteinsMetagenomeMicrobial metabolitesNutrikineticsPrebiotic health benefits

Identifiers

PMID26156216
PMCPMC4501371
OpenAlexW2126018988

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.